×
About 5,037 results

ALLMedicine™ Ewing Sarcoma Center

Research & Reviews  2,465 results

TARGETING EYA3 IN EWING SARCOMA RETARDS TUMOR GROWTH AND ANGIOGENESIS.
https://doi.org/10.1158/1535-7163.MCT-20-0749
Molecular Cancer Therapeutics; Wang Y, Pandey RN et. al.

Mar 2nd, 2021 - EWSR1/FLI1, the most common fusion gene in Ewing sarcoma, upregulates expression of the Eyes Absent 3 (EYA3) transactivator-phosphatase protein. The purpose of this study was to investigate molecular and cellular mechanisms through which EYA3 migh...

What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and...
https://doi.org/10.1097/CORR.0000000000001681
Clinical Orthopaedics and Related Research; Aryal A, Kumar VS et. al.

Feb 26th, 2021 - Skeletal metastases of bone sarcomas are indicators of poor prognosis. Various imaging modalities are available for their identification, which include bone scan, positron emission tomography/CT scan, MRI, and bone marrow aspiration/biopsy. Howeve...

Primary Ewing Sarcoma of Seminal Vesicle on PET/CT.
https://doi.org/10.1097/RLU.0000000000003539
Clinical Nuclear Medicine; Shen G, Yi C et. al.

Feb 25th, 2021 - Ewing sarcoma is an aggressive malignancy that most often presents as an undifferentiated primary bone tumor; less commonly, it arises in extraosseous soft tissues of mesenchymal cell origin. Primary extraosseous involvement of seminal vesicle is ...

Isolated Unilateral Orbital Metastasis From Ewing Sarcoma Detected on FDG PET/CT Scan.
https://doi.org/10.1097/RLU.0000000000003546
Clinical Nuclear Medicine; Agarwal R, Khare A et. al.

Feb 25th, 2021 - Ewing sarcoma is the second most common primary malignant bone tumor that usually affects diaphysis of long bones during the second decade of life. Isolated unilateral orbital metastasis from this tumor presenting as proptosis is extremely rare. H...

Histological response to neoadjuvant chemotherapy in localized Ewing sarcoma of the bon...
https://doi.org/10.1016/j.ejso.2021.02.009
European Journal of Surgical Oncology : the Journal of Th... Righi A, Pacheco M et. al.

Feb 24th, 2021 - The aim is to evaluate which of the existing scoring systems of histological response to neoadjuvant chemotherapy best stratifies the clinical outcome of patients with localized Ewing sarcoma of bone. 474 patients with diagnosis of localized Ewing...

see more →

Guidelines  4 results

Ewing Sarcoma Treatment (PDQ®)–Health Professional Version
https://www.cancer.gov/types/bone/hp/ewing-treatment-pdq

Aug 15th, 2019 - Ewing sarcoma treatment options include multidrug chemotherapy, surgery, and radiation therapy. Treatment approaches titrate therapeutic aggressiveness to maximizing local control while minimizing morbidity. Get detailed treatment information for ...

NCCN Guidelines Insights: Bone Cancer, Version 2.2017
http://www.jnccn.org/content/15/2/155.full
Biermann, J.,et al

Jan 31st, 2017 - The NCCN Guidelines for Bone Cancer provide interdisciplinary recommendations for treating chordoma, chondrosarcoma, giant cell tumor of bone, Ewing sarcoma, and osteosarcoma. These NCCN Guidelines Insights summarize the NCCN Bone Cancer Panel's g.

ENCCA WP17-WP7 consensus paper on teenagers and young adults (TYA) with bone sarcomas.
https://doi.org/10.1093/annonc/mdu153
Annals of Oncology : Official Journal of the European Soc... Wilhelm M, Dirksen U et. al.

Jun 25th, 2014 - Teenagers and young adults (TYA) cancer contributes substantially to morbidity and mortality in a population with much to offer society. TYA place distinct challenges upon cancer care services, many reporting feeling marginalized and their needs n...

Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the ...
https://doi.org/10.1002/pbc.21596
Pediatric Blood & Cancer; Meyer JS, Nadel HR et. al.

May 5th, 2008 - The Children's Oncology Group (COG) is a multi-institutional cooperative group dedicated to childhood cancer research that has helped to increase the survival of children with cancer through clinical trials. These clinical trials include a standar...

see more →

Drugs  9 results see all →

Clinicaltrials.gov  2,529 results

TARGETING EYA3 IN EWING SARCOMA RETARDS TUMOR GROWTH AND ANGIOGENESIS.
https://doi.org/10.1158/1535-7163.MCT-20-0749
Molecular Cancer Therapeutics; Wang Y, Pandey RN et. al.

Mar 2nd, 2021 - EWSR1/FLI1, the most common fusion gene in Ewing sarcoma, upregulates expression of the Eyes Absent 3 (EYA3) transactivator-phosphatase protein. The purpose of this study was to investigate molecular and cellular mechanisms through which EYA3 migh...

What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and...
https://doi.org/10.1097/CORR.0000000000001681
Clinical Orthopaedics and Related Research; Aryal A, Kumar VS et. al.

Feb 26th, 2021 - Skeletal metastases of bone sarcomas are indicators of poor prognosis. Various imaging modalities are available for their identification, which include bone scan, positron emission tomography/CT scan, MRI, and bone marrow aspiration/biopsy. Howeve...

Primary Ewing Sarcoma of Seminal Vesicle on PET/CT.
https://doi.org/10.1097/RLU.0000000000003539
Clinical Nuclear Medicine; Shen G, Yi C et. al.

Feb 25th, 2021 - Ewing sarcoma is an aggressive malignancy that most often presents as an undifferentiated primary bone tumor; less commonly, it arises in extraosseous soft tissues of mesenchymal cell origin. Primary extraosseous involvement of seminal vesicle is ...

Isolated Unilateral Orbital Metastasis From Ewing Sarcoma Detected on FDG PET/CT Scan.
https://doi.org/10.1097/RLU.0000000000003546
Clinical Nuclear Medicine; Agarwal R, Khare A et. al.

Feb 25th, 2021 - Ewing sarcoma is the second most common primary malignant bone tumor that usually affects diaphysis of long bones during the second decade of life. Isolated unilateral orbital metastasis from this tumor presenting as proptosis is extremely rare. H...

Histological response to neoadjuvant chemotherapy in localized Ewing sarcoma of the bon...
https://doi.org/10.1016/j.ejso.2021.02.009
European Journal of Surgical Oncology : the Journal of Th... Righi A, Pacheco M et. al.

Feb 24th, 2021 - The aim is to evaluate which of the existing scoring systems of histological response to neoadjuvant chemotherapy best stratifies the clinical outcome of patients with localized Ewing sarcoma of bone. 474 patients with diagnosis of localized Ewing...

see more →

News  21 results

Ewing Sarcoma Treatment (PDQ®)–Health Professional Version
https://www.cancer.gov/types/bone/hp/ewing-treatment-pdq

Aug 15th, 2019 - Ewing sarcoma treatment options include multidrug chemotherapy, surgery, and radiation therapy. Treatment approaches titrate therapeutic aggressiveness to maximizing local control while minimizing morbidity. Get detailed treatment information for ...

Chromoplexy linked to aggressive Ewing sarcomas
https://www.mdedge.com/sarcomajournal/article/176441/sarcoma-gist/chromoplexy-linked-aggressive-ewing-sarcomas
Mary Jo M. Dales

Sep 1st, 2018 - Chromoplexy, a sudden burst of complex, loop-like gene rearrangements that gives rise to a fusion gene, appears to be associated with aggressive Ewing sarcomas, based on a study of 124 tumors reported in Science. Ewing sarcomas with complex karyot.

Multiple solid tumors targeted by concept CAR T
https://www.mdedge.com/hematology-oncology/article/165978/sarcoma-gist/multiple-solid-tumors-targeted-concept-car-t/page/0/1

May 17th, 2018 - In contrast, B7-H3 is highly expressed on many different pediatric solid tumors, including rhabdomyosarcoma (95% of tumors stained), Ewing sarcoma (89%), Wilms tumor (100%), neuroblastoma (82%), ganglioneuroblastoma and ganglioneuroma (53%), medul.

Ewing sarcoma: Professional resources from the National Cancer Institute
https://www.mdedge.com/sarcomajournal/article/164473/ewings-sarcoma/ewing-sarcoma-professional-resources-national-cancer

Apr 27th, 2018 - Ewing Sarcoma Treatment (PDQ®)–Health Professional Version General Information About Ewing Sarcoma Go to Patient Version Dramatic improvements in survival have been achieved for children and adolescents with cancer. [ 1] Between 1975 and 2010, chil.

Updates of ongoing clinical trials
https://www.mdedge.com/sarcomajournal/article/164026/ewings-sarcoma/updates-ongoing-clinical-trials

Apr 23rd, 2018 - Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma NCT02306161 Sponsor: National Cancer Institut.

see more →

Patient Education  9 results see all →